Peri-operative immunoadsorption in sensitized renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 17, Issue 8, 2002, Pages 1503-1508

  Haas, Martin ^a   Böhmig, Georg A ^a   Leko Mohr, Zdenka ^a   Exner, Markus ^a   Regele, Heinz ^a   Derfler, Kurt ^a   Hörl, Walter H ^a   Druml, Wilfred ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

HLA antibodies; Humoral response; Hypersensitized patients; Immunoadsorption; Kidney re transplant; Kidney transplantaion; Renal graft rejection

Indexed keywords

ANTIBIOTIC AGENT; BIOCHEMICAL MARKER; COMPLEMENT COMPONENT C4D; CREATININE; CYCLOSPORIN; DEXAMETHASONE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PROTEIN A; STEROID; TACROLIMUS; ALLOANTIBODY;

ACUTE DISEASE; ADULT; AGED; ALLOIMMUNITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTEREMIA; CADAVER KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOADSORPTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RECIPIENT; REOPERATION; RETROSPECTIVE STUDY; SENSITIZATION; SEPTICEMIA; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINARY TRACT INFECTION; BIOPSY; BLOOD; CADAVER; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; PATHOLOGY; PEROPERATIVE CARE; TIME;

ADULT; AGED; BIOPSY; CADAVER; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSORBENT TECHNIQUES; INFECTION; INTRAOPERATIVE CARE; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS;

EID: 0035993288     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.8.1503     Document Type: Article

References (33)

1. Clinical syndromes associated with antibody in allografts
2. Collaborative transplant study-10-year report
3. The UNOS scientific renal transplant registry
4. Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match
5. Immunosuppressive regimens and their effects on renal allograft outcome
6. Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative Transplant Study
7. Effect of anti-lymphocyte antibody induction therapy on renal allograft survival
8. Immunologically high-risk recipient strategies
9. Advantage of antithymocyte globulin induction in sensitized kidney recipients: A randomized prospective study comparing induction with and without antithymocyte globulin
10. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients
11. Induction with polyclonal antibodies
12. Posttransplant anti-donor lymphocytotoxic antibody production in relation to graft outcome
13. The significance of the anti-class I response. I. Clinical and pathological features of anti-class I mediated rejection
14. The significance of the anti-class I response. II. Clinical and pathological features of renal transplants with anti-class I-like antibody
15. The humoral immune response towards HLA class II determinants in renal transplantation
16. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts
17. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics
18. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection
19. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: Evaluation of 602 sessions of extracorporeal immunoadsorption
20. Immunoadsorption in acute vascular rejection after renal transplantation
21. Immunoadsorption with protein A in humoral rejection of kidney transplants
22. Protein A immunoadsorption (IA) in renal transplantation patients with vascular rejection
23. The role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft
24. C4d-positive acute humoral renal allograft rejection: Effective treatment by immunoadsorption
25. Microdroplet assay of human serum cytotoxins
26. Plasma immunoadsorption treatment in patients with primary focal and segmental glomerulosclerosis
27. The Banff 97 working classification of renal allograft pathology
28. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification
29. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications
30. Capillary deposition of C4d complement fragment and early renal graft loss
31. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries
32. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation
33. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants